3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Squamous Cell Carcinoma of Head and Neck
4
Head and Neck Neoplasms
2
Virus Diseases
1
Tumor Virus Infections
1
Recurrence
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Locally Advanced Head and Neck HPV Negative Squamous Cell Cancers
1
Laryngeal Diseases
1
Hypoxia
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
Cisplatin
24
pembrolizumab
23
Magnetic Resonance Spectroscopy
19
Specimen Handling
16
Radiotherapy, Intensity-Modulated
12
Carboplatin
12
Cetuximab
11
1,2-diaminocyclohexaneplatinum II citrate
10
Platinum
9
Paclitaxel
9
Radiotherapy
6
Radiation
6
Fluorouracil
6
Biopsy
5
Taxes
4
Nivolumab
4
Docetaxel
4
(225)Ac-DOTA-c(RGDyK)
4
X-Rays
3
Pemetrexed
3
Fluorodeoxyglucose F18
3
reolysin
2
pralsetinib
2
ipatasertib
2
cemiplimab
2
atezolizumab
2
Surgical Procedures, Operative
2
Standard of Care
2
Radiotherapy, Image-Guided
2
Radiosurgery
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Carcinoma
×
Nimorazole
×
Head & Neck
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled